Literature DB >> 21288634

Glioblastoma multiforme in the Muir-Torre syndrome.

Zev A Binder1, Michael W Johnson, Avadhut Joshi, Christine L Hann, Constance A Griffin, Alessandro Olivi, Gregory J Riggins, Gary L Gallia.   

Abstract

Muir-Torre syndrome (MTS) is an autosomal dominant subtype of nonpolyposis colorectal carcinoma (HNPCC) characterized by the development of sebaceous gland tumors and visceral malignancies. The most common subtype of MTS is characterized by germline mutations in mismatch repair (MMR) genes leading to microsatellite instability (MSI). Central nervous system tumors have only rarely been associated with MTS. In this report, we describe the development of a glioblastoma multiforme (GBM) in a patient with MTS. Immunohistochemical analysis of the patient's colon carcinoma and his GBM both revealed loss of the mismatch repair proteins mutS homolog 2 (MSH2) and mutS homolog 6 (MSH6).
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21288634      PMCID: PMC4612635          DOI: 10.1016/j.clineuro.2010.12.011

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  14 in total

1.  Steady-state regulation of the human DNA mismatch repair system.

Authors:  D K Chang; L Ricciardiello; A Goel; C L Chang; C R Boland
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

Review 2.  Muir-Torre syndrome.

Authors:  Giovanni Ponti; Maurizio Ponz de Leon
Journal:  Lancet Oncol       Date:  2005-12       Impact factor: 41.316

3.  Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face.

Authors:  E G Muir; A J Bell; K A Barlow
Journal:  Br J Surg       Date:  1967-03       Impact factor: 6.939

4.  Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.

Authors:  Giovanni Ponti; Lorena Losi; Carmela Di Gregorio; Luca Roncucci; Monica Pedroni; Alessandra Scarselli; Piero Benatti; Stefania Seidenari; Giovanni Pellacani; Luigi Lembo; Giuseppina Rossi; Massimiliano Marino; Emanuela Lucci-Cordisco; Maurizio Ponz de Leon
Journal:  Cancer       Date:  2005-03-01       Impact factor: 6.860

5.  Molecular diagnosis of oligodendroglioma in paraffin sections.

Authors:  Kimmo J Hatanpaa; Peter C Burger; James R Eshleman; Kathleen M Murphy; Karin D Berg
Journal:  Lab Invest       Date:  2003-03       Impact factor: 5.662

6.  The frequency of Muir-Torre syndrome among Lynch syndrome families.

Authors:  Christopher D South; Heather Hampel; Ilene Comeras; Judith A Westman; Wendy L Frankel; Albert de la Chapelle
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

7.  The molecular basis of Turcot's syndrome.

Authors:  S R Hamilton; B Liu; R E Parsons; N Papadopoulos; J Jen; S M Powell; A J Krush; T Berk; Z Cohen; B Tetu
Journal:  N Engl J Med       Date:  1995-03-30       Impact factor: 91.245

8.  Identifying Muir-Torre syndrome in a patient with glioblastoma multiforme.

Authors:  Deric M Park; Gabrielle A Yeaney; Ronald L Hamilton; Jennifer Mabold; Nikki Urban; Leonard Appleman; John Flickinger; Frank Lieberman; Arlan Mintz
Journal:  Neuro Oncol       Date:  2008-11-21       Impact factor: 12.300

9.  The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome.

Authors:  H T Lynch; P M Lynch; J Pester; R M Fusaro
Journal:  Arch Intern Med       Date:  1981-04

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

View more
  2 in total

Review 1.  [Hereditary tumor syndromes in neuropathology].

Authors:  C Mawrin
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

2.  Glioblastoma multiforme as initial internal malignancy in Muir-Torre syndrome (MTS).

Authors:  Michael D Lehrer; Henry Lynch; David J Glembocki; Neel B Patel
Journal:  JAAD Case Rep       Date:  2015-10-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.